The role of renin-angiotensin system in cellular differentiation: Implications in pancreatic islet cell development and islet transplantation

Molecular and Cellular Endocrinology

Volumn 381, Issue 1-2, 2013, Pages 261-271

  Wang, Lin ^a   Leung, Po Sing ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

ACE2 Ang (1 7) Mas axis; Islet transplantation; Pancreatic stem cell differentiation; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; DIPEPTIDYL PEPTIDASE IV INHIBITOR; INSULIN RECEPTOR SUBSTRATE; MAS RECEPTOR; RENIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; DIABETES MELLITUS; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY DISEASE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; ORGANOGENESIS; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PANCREATIC PROGENITOR CELL; PANCREATIC STEM CELL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STEM CELL;

ACE2/ANG-(1-7)/MAS AXIS; ISLET TRANSPLANTATION; PANCREATIC STEM CELL DIFFERENTIATION; RENIN-ANGIOTENSIN SYSTEM;

ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; ORGANOGENESIS; REGENERATIVE MEDICINE; RENIN-ANGIOTENSIN SYSTEM; STEM CELLS;

EID: 84884129780     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.08.008     Document Type: Review

References (133)

1. Ager E.I., Chong W.W., Wen S.W., Christophi C. Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases. Cancer Cell Int. 2010, 10:19.
2. Ager E.I., Neo J., Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008, 29:1675-1684.
3. Bharadwaj M.S., Strawn W.B., Groban L., Yamaleyeva L.M., Chappell M.C., Horta C., Atkins K., Firmes L., Gurley S.B., Brosnihan K.B. Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction. Hypertension 2011, 58:852-858.
4. Bilman V., Mares-Guia L., Nadu A.P., Bader M., Campagnole-Santos M.J., Santos R.A., Santos S.H. Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7). Peptides 2012, 37:247-251.
5. Bindom S.M., Hans C.P., Xia H., Boulares A.H., Lazartigues E. Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Diabetes 2010, 59:2540-2548.
6. Bonner-Weir S., Weir G.C. New sources of pancreatic beta-cells. Nat. Biotechnol. 2005, 23:857-861.
7. Burns W.C., Velkoska E., Dean R., Burrell L.M., Thomas M.C. Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways. Am. J. Physiol. Renal Physiol. 2010, 299:F585-F593.
8. Carey R.M., Siragy H.M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 2003, 24:261-271.
9. Cesari M., Rossi G.P., Pessina A.C. Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J. Hypertens. 2002, 20:793-799.
10. Chan Y.C., Leung P.S. The renin-angiotensin system and reactive oxygen species: implications in pancreatitis. Antioxid. Redox Signal. 2011, 15:2743-2755.
11. Chandra V., Swetha G., Muthyala S., Jaiswal A.K., Bellare J.R., Nair P.D., Bhonde R.R. Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS ONE 2011, 6:e20615.
12. Chao K.C., Chao K.F., Fu Y.S., Liu S.H. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS ONE 2008, 3:e1451.
13. Chappell M.C. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?. Hypertension 2007, 50:596-599.
14. Chen J., Xiao X., Chen S., Zhang C., Yi D., Shenoy V., Raizada M.K., Zhao B., Chen Y. Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy. Hypertension 2013, 61:681-689.
15. Cheng Q., Law P.K., de Gasparo M., Leung P.S. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. J. Pharmacol. Exp. Ther. 2008, 327:683-691.
16. Cheng Q., Leung P.S. An update on the islet renin-angiotensin system. Peptides 2011, 32:1087-1095.
17. Chhabra K.H., Xia H., Pedersen K.B., Speth R.C., Lazartigues E. Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E874-E884.
18. Chow L., Rezmann L., Imamura K., Wang L., Catt K., Tikellis C., Louis W.J., Frauman A.G., Louis S.N. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. Prostate 2008, 68:651-660.
19. Chu K.Y., Cheng Q., Chen C., Au L.S., Seto S.W., Tuo Y., Motin L., Kwan Y.W., Leung P.S. Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic beta-cells via angiotensin II type 2 receptors. Am. J. Physiol. Cell Physiol. 2010, 298:C313-C323.
20. Chu K.Y., Leung P.S. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid. Redox Signal. 2007, 9:869-878.
21. Clarke N.E., Turner A.J. Angiotensin-converting enzyme 2: the first decade. Int. J. Hypertens. 2012, 2012:307315.
22. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000, 52:415-472.
23. de Resende M.M., Stodola T.J., Greene A.S. Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis. Physiol. Genomics 2010, 42:437-444.
24. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., Qian D., Lam J.S., Ailles L.E., Wong M., Joshua B., Kaplan M.J., Wapnir I., Dirbas F.M., Somlo G., Garberoglio C., Paz B., Shen J., Lau S.K., Quake S.R., Brown J.M., Weissman I.L., Clarke M.F. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
25. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E., Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
26. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000, 87:E1-E9.
27. Durik M., Seva Pessoa B., Roks A.J. The renin-angiotensin system, bone marrow and progenitor cells. Clin. Sci. (Lond). 2012, 123:205-223.
28. Ellefson D.D., diZerega G.S., Espinoza T., Roda N., Maldonado S., Rodgers K.E. Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother. Pharmacol. 2004, 53:15-24.
29. Endtmann C., Ebrahimian T., Czech T., Arfa O., Laufs U., Fritz M., Wassmann K., Werner N., Petoumenos V., Nickenig G., Wassmann S. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension 2011, 58:394-403.
30. Feng Y., Ni L., Wan H., Fan L., Fei X., Ma Q., Gao B., Xiang Y., Che J., Li Q. Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro. Oncol. Rep. 2011, 26:1157-1164.
31. Furuhashi M., Ura N., Takizawa H., Yoshida D., Moniwa N., Murakami H., Higashiura K., Shimamoto K. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J. Hypertens. 2004, 22:1977-1982.
32. Gallo R., Gambelli F., Gava B., Sasdelli F., Tellone V., Masini M., Marchetti P., Dotta F., Sorrentino V. Generation and expansion of multipotent mesenchymal progenitor cells from cultured human pancreatic islets. Cell Death Differ. 2007, 14:1860-1871.
33. Gao F., Wu D.Q., Hu Y.H., Jin G.X., Li G.D., Sun T.W., Li F.J. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl. Res. 2008, 151:293-302.
34. Giani J.F., Mayer M.A., Munoz M.C., Silberman E.A., Hocht C., Taira C.A., Gironacci M.M., Turyn D., Dominici F.P. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E262-E271.
35. Gomez R.A., Lynch K.R., Chevalier R.L., Wilfong N., Everett A., Carey R.M., Peach M.J. Renin and angiotensinogen gene expression in maturing rat kidney. Am. J. Physiol. 1988, 254:F582-F587.
36. Goyal R., Leitzke A., Goyal D., Gheorghe C.P., Longo L.D. Antenatal maternal hypoxic stress: adaptations in fetal lung Renin-Angiotensin system. Reprod. Sci. 2011, 18:180-189.
37. Greco S., Muscella A., Elia M.G., Salvatore P., Storelli C., Marsigliante S. Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells. J. Endocrinol. 2002, 174:205-214.
38. Griffing G.T., Melby J.C. Enalapril (MK-421) and the white cell count and haematocrit. Lancet 1982, 1:1361.
39. Han H.J., Han J.Y., Heo J.S., Lee S.H., Lee M.Y., Kim Y.H. ANG II-stimulated DNA synthesis is mediated by ANG II receptor-dependent Ca(2+)/PKC as well as EGF receptor-dependent PI3K/Akt/mTOR/p70S6K1 signal pathways in mouse embryonic stem cells. J. Cell. Physiol. 2007, 211:618-629.
40. Henriksen, E.J., Jacob, S., Augustin, H.J., Dietze, G.J., 1996. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes. 45 Suppl 1, S125-128.
41. Heringer-Walther S., Eckert K., Schumacher S.M., Uharek L., Wulf-Goldenberg A., Gembardt F., Fichtner I., Schultheiss H.P., Rodgers K., Walther T. Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 2009, 94:857-860.
42. Huang Z., Yu J., Toselli P., Bhawan J., Sudireddy V., Taylor L., Polgar P. Angiotensin II type 1 and bradykinin B2 receptors expressed in early stage epithelial cells derived from human embryonic stem cells. J. Cell. Physiol. 2007, 211:816-825.
43. Ishizuka T., Goshima H., Ozawa A., Watanabe Y. Effect of angiotensin II on proliferation and differentiation of mouse induced pluripotent stem cells into mesodermal progenitor cells. Biochem. Biophys. Res. Commun. 2012, 420:148-155.
44. Iwai M., Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens. Res. 2009, 32:533-536.
45. Iwanami J., Mogi M., Li J.M., Tsukuda K., Min L.J., Sakata A., Fujita T., Iwai M., Horiuchi M. Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke 2008, 39:2554-2559.
46. Jarajapu Y.P., Bhatwadekar A.D., Caballero S., Hazra S., Shenoy V., Medina R., Kent D., Stitt A.W., Thut C., Finney E.M., Raizada M.K., Grant M.B. Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors. Diabetes 2013, 62:1258-1269.
47. Jiang F.X., Morahan G. Pancreatic stem cells: from possible to probable. Stem Cell Rev. 2012, 8:647-657.
48. Jiang J., Au M., Lu K., Eshpeter A., Korbutt G., Fisk G., Majumdar A.S. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007, 25:1940-1953.
49. Jurewicz M., Yang S., Augello A., Godwin J.G., Moore R.F., Azzi J., Fiorina P., Atkinson M., Sayegh M.H., Abdi R. Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes 2010, 59:3139-3147.
50. Kampf C., Lau T., Olsson R., Leung P.S., Carlsson P.O. Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts. Diabetologia 2005, 48:1159-1167.
51. Kim Y.H., Han H.J. Synergistic effect of high glucose and ANG II on proliferation of mouse embryonic stem cells: involvement of PKC and MAPKs as well as AT1 receptor. J. Cell. Physiol. 2008, 215:374-382.
52. Kim Y.M., Jeon E.S., Kim M.R., Jho S.K., Ryu S.W., Kim J.H. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells. Int. J. Biochem. Cell Biol. 2008, 40:2482-2491.
53. Lam K.Y., Leung P.S. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur. J. Endocrinol. 2002, 146:567-572.
54. Lau T., Carlsson P.O., Leung P.S. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004, 47:240-248.
55. Lau S.T., Leung P.S. Role of the RAS in pancreatic cancer. Curr. Cancer Drug Targets 2011, 11:412-420.
56. Lee R.H., Seo M.J., Reger R.L., Spees J.L., Pulin A.A., Olson S.D., Prockop D.J. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 2006, 103:17438-17443.
57. Leung K.K., Liang J., Ma M.T., Leung P.S. Angiotensin II type 2 receptor is critical for the development of human fetal pancreatic progenitor cells into islet-like cell clusters and their potential for transplantation. Stem Cells 2012, 30:525-536.
58. Leung P.S. The physiology of a local renin-angiotensin system in the pancreas. J. Physiol. 2007, 580:31-37.
59. Leung P.S. Current research concerning the RAS in pancreatic stem cells. Adv. Exp. Med. Biol. 2010, 690:155-177.
60. Leung P.S., Carlsson P.O. Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus. Pancreas 2005, 30:293-298.
61. Leung P.S., Chan H.C., Fu L.X., Wong P.Y. Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J. Endocrinol. 1997, 153:269-274.
62. Leung P.S., Chappell M.C. A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int. J. Biochem. Cell Biol. 2003, 35:838-846.
63. Leung P.S., Ng K.Y. Current progress in stem cell research and its potential for islet cell transplantation. Curr. Mol. Med. 2013, 13:109-125.
64. Lewandowski D., Barroca V., Duconge F., Bayer J., Van Nhieu J.T., Pestourie C., Fouchet P., Tavitian B., Romeo P.H. In vivo cellular imaging pinpoints the role of reactive oxygen species in the early steps of adult hematopoietic reconstitution. Blood 2010, 115:443-452.
65. Li W.C., Rukstalis J.M., Nishimura W., Tchipashvili V., Habener J.F., Sharma A., Bonner-Weir S. Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats. J. Cell Sci. 2010, 123:2792-2802.
66. Liang J., Leung K.K., Lam S.Y., Leung P.S. Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells. Diabetes Obes. Metab. 2012, 14:842-851.
67. Liang Q.L., Mo Z., Li X.F., Wang X.X., Li R.M. Pdx1 protein induces human embryonic stem cells into the pancreatic endocrine lineage. Cell Biol. Int. 2013, 37:2-10.
68. Liu C., Lv X.H., Li H.X., Cao X., Zhang F., Wang L., Yu M., Yang J.K. Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes. Acta Diabetol. 2012, 49:291-299.
69. Liu H.W., Cheng B., Fu X.B., Sun T.Z., Li J.F. Characterization of AT1 and AT2 receptor expression profiles in human skin during fetal life. J. Dermatol. Sci. 2007, 46:221-225.
70. Maehr R., Chen S., Snitow M., Ludwig T., Yagasaki L., Goland R., Leibel R.L., Melton D.A. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl. Acad. Sci. USA 2009, 106:15768-15773.
71. Matsushita K., Wu Y., Okamoto Y., Pratt R.E., Dzau V.J. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 2006, 48:1095-1102.
72. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., Oldfield B.J., Mendelsohn F.A., Chai S.Y. The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 2003, 35:901-918.
73. Milanesi A., Lee J.W., Li Z., Da Sacco S., Villani V., Cervantes V., Perin L., Yu J.S. Beta-cell regeneration mediated by human bone marrow mesenchymal stem cells. PLoS ONE 2012, 7:e42177.
74. Moritz K.M., Campbell D.J., Wintour E.M. Angiotensin-(1-7) in the ovine fetus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R404-R409.
75. Muller P., Kazakov A., Jagoda P., Semenov A., Bohm M., Laufs U. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload. Cardiovasc. Res. 2009, 83:106-114.
76. Ni L., Feng Y., Wan H., Ma Q., Fan L., Qian Y., Li Q., Xiang Y., Gao B. Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways. Oncol. Rep. 2012, 27:783-790.
77. Nogueira-Silva C., Carvalho-Dias E., Piairo P., Nunes S., Baptista M.J., Moura R.S., Correia-Pinto J. Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia. Mol. Med. 2012, 18:231-243.
78. Nogueira A.I., Souza Santos R.A., Simoes E.S.A.C., Cabral A.C., Vieira R.L., Drumond T.C., Machado L.J., Freire C.M., Ribeiro-Oliveira A. The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes. Regul. Pept. 2007, 141:55-60.
79. Numasawa Y., Kimura T., Miyoshi S., Nishiyama N., Hida N., Tsuji H., Tsuruta H., Segawa K., Ogawa S., Umezawa A. Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis. Stem Cells. 2011, 29:1405-1414.
80. Okura H., Komoda H., Fumimoto Y., Lee C.M., Nishida T., Sawa Y., Matsuyama A. Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. J Artif. Organs. 2009, 12:123-130.
81. Oudit G.Y., Herzenberg A.M., Kassiri Z., Wong D., Reich H., Khokha R., Crackower M.A., Backx P.H., Penninger J.M., Scholey J.W. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am. J. Pathol. 2006, 168:1808-1820.
82. Pan N., Frome W.L., Dart R.A., Tewksbury D., Luo J. Expression of the renin-angiotensin system in a human placental cell line. Clin. Med. Res. 2013, 11:1-6.
83. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
84. Passos-Silva D.G., Verano-Braga T., Santos R.A. Angiotensin-(1-7): beyond the cardio-renal actions. Clin. Sci. (Lond). 2013, 124:443-456.
85. Paul M., Poyan Mehr A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 2006, 86:747-803.
86. Phadnis S.M., Joglekar M.V., Dalvi M.P., Muthyala S., Nair P.D., Ghaskadbi S.M., Bhonde R.R., Hardikar A.A. Human bone marrow-derived mesenchymal cells differentiate and mature into endocrine pancreatic lineage in vivo. Cytotherapy 2011, 13:279-293.
87. Pringle K.G., Tadros M.A., Callister R.J., Lumbers E.R. The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis?. Placenta 2011, 32:956-962.
88. Qi Y., Shenoy V., Wong F., Li H., Afzal A., Mocco J., Sumners C., Raizada M.K., Katovich M.J. Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Exp. Physiol. 2011, 96:863-874.
89. Reinhard H., Jacobsen P.K., Lajer M., Pedersen N., Billestrup N., Mandrup-Poulsen T., Parving H.H., Rossing P. Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. Diabetologia 2010, 53:2129-2133.
90. Roccanova L., Ramphal P. The role of stem cells in the evolution of longevity and its application to tissue therapy. Tissue Cell 2003, 35:79-81.
91. Rodgers K., Xiong S., DiZerega G.S. Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemother. Pharmacol. 2003, 51:97-106.
92. Rodgers K.E., Oliver J., diZerega G.S. Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother. Pharmacol. 2006, 57:559-568.
93. Rodgers K.E., Xiong S., Steer R., diZerega G.S. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells. 2000, 18:287-294.
94. Sagawa K., Nagatani K., Komagata Y., Yamamoto K. Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice. Arthritis Rheum. 2005, 52:1920-1928.
95. Sakata N., Goto M., Yoshimatsu G., Egawa S., Unno M. Utility of co-transplanting mesenchymal stem cells in islet transplantation. World J. Gastroenterol. 2011, 17:5150-5155.
96. Saleem S., Li J., Yee S.P., Fellows G.F., Goodyer C.G., Wang R. Beta1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival. J. Pathol. 2009, 219:182-192.
97. Sampaio W.O., Souza dos Santos R.A., Faria-Silva R., da Mata Machado L.T., Schiffrin E.L., Touyz R.M. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007, 49:185-192.
98. Sanchez S.I., Seltzer A.M., Fuentes L.B., Forneris M.L., Ciuffo G.M. Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. Eur. J. Pharmacol. 2008, 588:114-123.
99. Santos R.A., Ferreira A.J. Angiotensin-(1-7) and the renin-angiotensin system. Curr. Opin. Nephrol. Hypertens. 2007, 16:122-128.
100. Santos R.A., Simoes e Silva A.C., Maric C., Silva D.M., Machado R.P., de Buhr I., Heringer-Walther S., Pinheiro S.V., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. USA 2003, 100:8258-8263.
101. Santos S.H., Braga J.F., Mario E.G., Porto L.C., Rodrigues-Machado Mda G., Murari A., Botion L.M., Alenina N., Bader M., Santos R.A. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler. Thromb. Vasc. Biol. 2010, 30:953-961.
102. Savary K., Michaud A., Favier J., Larger E., Corvol P., Gasc J.M. Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo. Blood 2005, 105:103-110.
103. Schulz T.C., Young H.Y., Agulnick A.D., Babin M.J., Baetge E.E., Bang A.G., Bhoumik A., Cepa I., Cesario R.M., Haakmeester C., Kadoya K., Kelly J.R., Kerr J., Martinson L.A., McLean A.B., Moorman M.A., Payne J.K., Richardson M., Ross K.G., Sherrer E.S., Song X., Wilson A.Z., Brandon E.P., Green C.E., Kroon E.J., Kelly O.G., D'Amour K.A., Robins A.J. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS ONE 2012, 7:e37004.
104. Schutz S., Le Moullec J.M., Corvol P., Gasc J.M. Early expression of all the components of the renin-angiotensin-system in human development. Am. J. Pathol. 1996, 149:2067-2079.
105. Shim J.H., Kim S.E., Woo D.H., Kim S.K., Oh C.H., McKay R., Kim J.H. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 2007, 50:1228-1238.
106. Steckelings U.M., Henz B.M., Wiehstutz S., Unger T., Artuc M. Differential expression of angiotensin receptors in human cutaneous wound healing. Br. J. Dermatol. 2005, 153:887-893.
107. Suen P.M., Zou C., Zhang Y.A., Lau T.K., Chan J., Yao K.M., Leung P.S. PDZ-domain containing-2 (PDZD2) is a novel factor that affects the growth and differentiation of human fetal pancreatic progenitor cells. Int. J. Biochem. Cell Biol. 2008, 40:789-803.
108. Tahmasebi M., Puddefoot J.R., Inwang E.R., Vinson G.P. The tissue renin-angiotensin system in human pancreas. J. Endocrinol. 1999, 161:317-322.
109. Takeda M., Yamamoto K., Takemura Y., Takeshita H., Hongyo K., Kawai T., Hanasaki-Yamamoto H., Oguro R., Takami Y., Tatara Y., Takeya Y., Sugimoto K., Kamide K., Ohishi M., Rakugi H. Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes 2013, 62:223-233.
110. Tassone E.J., Sciacqua A., Andreozzi F., Presta I., Perticone M., Carnevale D., Casaburo M., Hribal M.L., Sesti G., Perticone F. Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. Cardiovasc. Res. 2013, 99:129-136.
111. Tikellis C., Bialkowski K., Pete J., Sheehy K., Su Q., Johnston C., Cooper M.E., Thomas M.C. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008, 57:1018-1025.
112. Timper K., Seboek D., Eberhardt M., Linscheid P., Christ-Crain M., Keller U., Muller B., Zulewski H. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem. Biophys. Res. Commun. 2006, 341:1135-1140.
113. Todorov I., Nair I., Ferreri K., Rawson J., Kuroda A., Pascual M., Omori K., Valiente L., Orr C., Al-Abdullah I., Riggs A., Kandeel F., Mullen Y. Multipotent progenitor cells isolated from adult human pancreatic tissue. Transplant Proc. 2005, 37:3420-3421.
114. Ushio-Fukai M., Urao N. Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. Antioxid. Redox Signal. 2009, 11:2517-2533.
115. Van Hoof D., Liku M.E. Directed differentiation of human pluripotent stem cells along the pancreatic endocrine lineage. Methods Mol. Biol. 2013, 997:127-140.
116. Voltarelli J.C., Couri C.E., Stracieri A.B., Oliveira M.C., Moraes D.A., Pieroni F., Coutinho M., Malmegrim K.C., Foss-Freitas M.C., Simoes B.P., Foss M.C., Squiers E., Burt R.K. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007, 297:1568-1576.
117. Wang Y., Qian C., Roks A.J., Westermann D., Schumacher S.M., Escher F., Schoemaker R.G., Reudelhuber T.L., van Gilst W.H., Schultheiss H.P., Tschope C., Walther T. Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circ. Heart Fail. 2010, 3:286-293.
118. Wassmann S., Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J. Hypertens. Suppl. 2006, 24:S15-S21.
119. Wiener R.S., Cao Y.X., Hinds A., Ramirez M.I., Williams M.C. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung. J. Cell. Biochem. 2007, 101:1278-1291.
120. Wolf G. Angiotensin II and tubular development. Nephrol. Dial. Transplant. 2002, 17(Suppl 9):48-51.
121. Wong T.P., Ho K.Y., Ng E.K., Debnam E.S., Leung P.S. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E669-E681.
122. Wright J.W., Harding J.W. Brain renin-angiotensin - a new look at an old system. Prog. Neurobiol. 2011, 95:49-67.
123. Xu X., D'Hoker J., Stange G., Bonne S., De Leu N., Xiao X., Van de Casteele M., Mellitzer G., Ling Z., Pipeleers D., Bouwens L., Scharfmann R., Gradwohl G., Heimberg H. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132:197-207.
124. Yamada S., Yamamoto Y., Nagasawa M., Hara A., Kodera T., Kojima I. In vitro transdifferentiation of mature hepatocytes into insulin-producing cells. Endocr. J. 2006, 53:789-795.
125. Yao E.H., Fukuda N., Matsumoto T., Kobayashi N., Katakawa M., Yamamoto C., Tsunemi A., Suzuki R., Ueno T., Matsumoto K. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens. Res. 2007, 30:1119-1128.
126. You D., Cochain C., Loinard C., Vilar J., Mees B., Duriez M., Levy B.I., Silvestre J.S. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 2008, 325:766-773.
127. Yu Y., Wang Y., Zhou L.N., Zheng F. ARB treatment prevents the decrease in endothelial progenitor cells and the loss of renal microvasculature in remnant kidney. Am. J. Nephrol. 2011, 33:550-557.
128. Zambidis E.T., Park T.S., Yu W., Tam A., Levine M., Yuan X., Pryzhkova M., Peault B. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008, 112:3601-3614.
129. Zhang D., Jiang W., Liu M., Sui X., Yin X., Chen S., Shi Y., Deng H. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 2009, 19:429-438.
130. Zheng X., Wu Y., Zhu L., Chen Q., Zhou Y., Yan H., Chen T., Xiao Q., Zhu J., Zhang L. Angiotensin II promotes differentiation of mouse embryonic stem cells to smooth muscle cells through PI3-kinase signaling pathway and NF-kappaB. Differentiation 2013, 85:41-54.
131. Zhong J., Guo D., Chen C.B., Wang W., Schuster M., Loibner H., Penninger J.M., Scholey J.W., Kassiri Z., Oudit G.Y. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension 2011, 57:314-322.
132. Zhou L., Zhang R., Zhang L., Yao W., Li J., Yuan Y. Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy. Cancer Lett. 2011, 307:18-25.
133. Zhou Q., Brown J., Kanarek A., Rajagopal J., Melton D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455:627-632.